Rosen Law Firm Alerts Investors to Potential Lawsuit Against Reckitt Benckiser Over Misleading Claims and Product Safety Issues

Rosen Law Firm Alerts Investors to Potential Legal Action Against Reckitt Benckiser Group PLC (OTC: RBGLY) Over Alleged Misleading Statements and Product Safety Concerns New York—The Rosen Law Firm, a prominent global investor rights legal organization, has issued a reminder to shareholders regarding a class action lawsuit concerning Reckitt Benckiser Group PLC (OTC: RBGLY). The lawsuit pertains to purchases of the company's American Depositary Shares (ADSs) made between January 13, 2021, and July 28, 2024. Reckitt describes itself as a UK-based multinational specializing in consumer health and household products. Interested investors can submit inquiries via a provided form, contact attorney Phillip Kim directly, or call their office at 866-767-3653. The Investigation: Rosen Law Firm is examining claims that Reckitt Benckiser may have misrepresented critical information about its business practices. Specifically, the lawsuit alleges that during the class period, Reckitt failed to disclose that its Enfamil formula could increase the risk of necrotizing enterocolitis (NEC) in preterm infants, potentially impacting sales and exposing the company to legal liabilities. The lawsuit ...